NCT00939627 2026-03-10Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent CetuximabNational Cancer Institute (NCI)Phase 2 Completed55 enrolled 10 charts
NCT01946529 2026-02-23Therapeutic Trial for Patients With Ewing Sarcoma Family of Tumor and Desmoplastic Small Round Cell TumorsSt. Jude Children's Research HospitalPhase 2 Active not recruiting24 enrolled 11 charts